Squarepoint
BNTX icon

Squarepoint’s BioNTech BNTX Stock Holding History

Squarepoint’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5M Buy
199,004
+116,155
+140% +$10.9M 0.02% 733
2026
Q1 		$7.36M Buy
82,849
+49,105
+146% +$5.05M 0.01% 1248
2025
Q4 		$3.21M Sell
33,744
-42,160
-56% -$4.25M ﹤0.01% 1750
2025
Q3 		$7.49M Sell
75,904
-259,756
-77% -$27.8M 0.01% 1227
2025
Q2 		$35.7M Sell
335,660
-12,067
-3% -$1.22M 0.04% 509
2025
Q1 		$31.7M Sell
347,727
-21,912
-6% -$2.45M 0.04% 488
2024
Q4 		$42.1M Buy
369,639
+44,940
+14% +$5.13M 0.04% 435
2024
Q3 		$38.6M Buy
324,699
+46,027
+17% +$4.23M 0.06% 324
2024
Q2 		$22.4M Sell
278,672
-54,939
-16% -$5.02M 0.04% 535
2024
Q1 		$30.8M Buy
333,611
+17,312
+5% +$1.66M 0.05% 430
2023
Q4 		$33.4M Buy
316,299
+291,080
+1,154% +$29.3M 0.06% 354
2023
Q3 		$2.74M Sell
25,219
-21,235
-46% -$2.35M 0.01% 1569
2023
Q2 		$5.01M Buy
46,454
+22,699
+96% +$2.55M 0.02% 1081
2023
Q1 		$2.96M Buy
23,755
+8,059
+51% +$1.11M 0.01% 1171
2022
Q4 		$2.36M Buy
+15,696
New +$2.42M 0.01% 1271
2022
Q3 		– Sell
-30,104
Closed -$4.49M – 3003
2022
Q2 		$4.49M Buy
30,104
+9,253
+44% +$1.41M 0.03% 736
2022
Q1 		$3.56M Buy
20,851
+11,356
+120% +$1.91M 0.02% 859
2021
Q4 		$2.45M Sell
9,495
-4,498
-32% -$1.23M 0.01% 1139
2021
Q3 		$3.82M Buy
13,993
+5,214
+59% +$1.66M 0.01% 901
2021
Q2 		$1.97M Buy
+8,779
New +$1.66M 0.01% 1193
2021
Q1 		– Sell
-21,233
Closed -$1.73M – 3136
2020
Q4 		$1.73M Buy
21,233
+12,484
+143% +$1.23M 0.01% 1013
2020
Q3 		$606K Buy
8,749
+3,542
+68% +$254K 0.01% 1291
2020
Q2 		$348K Buy
+5,207
New +$260K 0.01% 1514

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Squarepoint's BNTX Position: Q2 2026 in Review

Squarepoint increased its BioNTech (BNTX) stake by 140% in Q2 2026, buying an estimated $10.9M and bringing the position to 199,004 shares worth $18.5M. The position accounts for 0.02% of the portfolio, ranked #733.

Squarepoint first reported a position in BNTX in Q2 2020 and has held it in 23 quarters since. The position peaked at $42.1M in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Squarepoint held 199,004 shares of BioNTech worth $18.5M as of Q2 2026.
  • Squarepoint bought 116,155 BioNTech shares in Q2 2026, an estimated $10.9M.
  • BioNTech made up 0.02% of Squarepoint's portfolio in Q2 2026, its #733 holding.
  • Squarepoint first reported a position in BioNTech in Q2 2020 and has held it in 23 quarters since.
  • Squarepoint's BioNTech position peaked at $42.1M in Q4 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.